Rentokil Initial PLC
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, Europe, the United Kingdom, Asia, the Middle East, North Africa, Turkey, and Pacific. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management. The company provides hygiene services, including the provision and maintena… Read more
Market Cap & Net Worth: Rentokil Initial PLC (RTO)
Rentokil Initial PLC (NYSE:RTO) has a market capitalization of $16.29 Billion ($16.29 Billion) as of March 19, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1209 globally and #930 in its home market, demonstrating a 2.53% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rentokil Initial PLC's stock price $32.39 by its total outstanding shares 502927977 (502.93 Million).
Rentokil Initial PLC Market Cap History: 2015 to 2026
Rentokil Initial PLC's market capitalization history from 2015 to 2026. Data shows growth from $5.27 Billion to $16.29 Billion (11.79% CAGR).
Rentokil Initial PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rentokil Initial PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.34x
Rentokil Initial PLC's market cap is 2.34 times its annual revenue
1.20x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
41.48x
Rentokil Initial PLC's market cap is 41.48 times its annual earnings
25.18x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $5.27 Billion | $1.76 Billion | $124.30 Million | 3.00x | 42.44x |
| 2016 | $6.17 Billion | $2.17 Billion | $167.50 Million | 2.84x | 36.81x |
| 2017 | $10.05 Billion | $2.41 Billion | $682.80 Million | 4.17x | 14.72x |
| 2018 | $10.04 Billion | $2.47 Billion | -$98.30 Million | 4.06x | N/A |
| 2019 | $14.31 Billion | $2.68 Billion | $283.80 Million | 5.35x | 50.43x |
| 2020 | $16.87 Billion | $2.79 Billion | $186.00 Million | 6.05x | 90.70x |
| 2021 | $19.30 Billion | $2.95 Billion | $263.00 Million | 6.53x | 73.37x |
| 2022 | $15.00 Billion | $3.71 Billion | $232.00 Million | 4.04x | 64.65x |
| 2023 | $14.11 Billion | $5.38 Billion | $381.00 Million | 2.63x | 37.04x |
| 2024 | $12.73 Billion | $5.44 Billion | $307.00 Million | 2.34x | 41.48x |
Competitor Companies of RTO by Market Capitalization
Companies near Rentokil Initial PLC in the global market cap rankings as of March 19, 2026.
Key companies related to Rentokil Initial PLC by market ranking:
- Cintas Corporation (NASDAQ:CTAS): Ranked #328 globally with a market cap of $65.93 Billion USD.
- Relx PLC (PINK:RLXXF): Ranked #390 globally with a market cap of $56.43 Billion USD.
- Copart Inc (NASDAQ:CPRT): Ranked #683 globally with a market cap of $30.07 Billion USD.
- Thomson Reuters Corp (NYSE:TRI): Ranked #878 globally with a market cap of $22.59 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #328 | Cintas Corporation | NASDAQ:CTAS | $65.93 Billion | $192.84 |
| #390 | Relx PLC | PINK:RLXXF | $56.43 Billion | $48.91 |
| #683 | Copart Inc | NASDAQ:CPRT | $30.07 Billion | $34.05 |
| #878 | Thomson Reuters Corp | NYSE:TRI | $22.59 Billion | $165.98 |
Rentokil Initial PLC Historical Marketcap From 2015 to 2026
Between 2015 and today, Rentokil Initial PLC's market cap moved from $5.27 Billion to $ 16.29 Billion, with a yearly change of 11.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $16.29 Billion | +9.95% |
| 2025 | $14.82 Billion | +16.35% |
| 2024 | $12.73 Billion | -9.78% |
| 2023 | $14.11 Billion | -5.90% |
| 2022 | $15.00 Billion | -22.27% |
| 2021 | $19.30 Billion | +14.38% |
| 2020 | $16.87 Billion | +17.88% |
| 2019 | $14.31 Billion | +42.51% |
| 2018 | $10.04 Billion | -0.10% |
| 2017 | $10.05 Billion | +63.05% |
| 2016 | $6.17 Billion | +16.89% |
| 2015 | $5.27 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Rentokil Initial PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.29 Billion USD |
| MoneyControl | $16.29 Billion USD |
| MarketWatch | $16.29 Billion USD |
| marketcap.company | $16.29 Billion USD |
| Reuters | $16.29 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.